Bill
Bill > A1154
NJ A1154
NJ A1154Requires physicians and other prescribers to obtain electronic or written consent for certain medications with "black box warnings."
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This bill requires physicians, physician assistants, advanced practice nurses, and other authorized prescribers to obtain informed electronic or written consent prior to prescribing them psychotropic medications that are accompanied by a "black box warning," which consent is to include an electronic or a written acknowledgement that the patient or the patient's guardian received notification about the black box warning. The bill specifies that in cases where electronic or written consent cannot be obtained but oral consent is provided, the prescriber must make a notation in the patient's file indicating the date and circumstances of the informed consent. The United States Food and Drug Administration (FDA) requires pharmaceutical companies to place a "black box warning" on a drug label if medical studies indicate that the drug carries a significant risk of serious or life-threatening adverse effects. A "black box warning" is the strongest warning that the FDA requires. A physician, physician assistant, advanced practice nurse, or other authorized prescriber who violates the requirements established under the bill is subject to disciplinary action by the applicable State professional licensing board.
AI Summary
This bill requires physicians, physician assistants, advanced practice nurses, and other authorized prescribers to obtain informed consent, either electronically or in writing, before prescribing psychotropic medications that carry a "black box warning," which is the strongest warning issued by the U.S. Food and Drug Administration (FDA) indicating significant risks of serious or life-threatening side effects. This consent must acknowledge that the patient or their guardian has been informed about the black box warning and authorizes the prescription. If electronic or written consent is not feasible, oral consent can be obtained, but the prescriber must document the date and circumstances of this consent in the patient's file. Prescribers who violate these requirements will face disciplinary action from their respective State professional licensing boards, such as the State Board of Medical Examiners or the New Jersey Board of Nursing. The bill also mandates that the Division of Consumer Affairs, in consultation with the Department of Health, will establish necessary rules and regulations for its implementation, and the act will become effective 180 days after it is enacted.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/A1154 |
| BillText | https://pub.njleg.gov/Bills/2026/A1500/1154_I1.HTM |
Loading...